A Glimmer of Hope: NKGen Biotech's Trocleucel Shows Remarkable Cognitive Gains in Parkinson's Trial
LB Pharma Ignites Wall Street with Dazzling Trading Debut, Shares Soar on Schizophrenia Drug Promise